392 related articles for article (PubMed ID: 11844238)
21. Combined revascularization surgery for childhood moyamoya disease: STA-MCA and encephalo-duro-arterio-myo-synangiosis.
Houkin K; Kamiyama H; Takahashi A; Kuroda S; Abe H
Childs Nerv Syst; 1997 Jan; 13(1):24-9. PubMed ID: 9083698
[TBL] [Abstract][Full Text] [Related]
22. Modified encephalo-duro-periosteal-synangiosis (EDPS) for the revascularization of anterior cerebral artery territory in moyamoya disease: A single-center experience.
Zhao Y; Yu S; Li J; Lu J; Zhang Q; Zhang D; Wang R; Zhao Y
Clin Neurol Neurosurg; 2019 Mar; 178():86-92. PubMed ID: 30763783
[TBL] [Abstract][Full Text] [Related]
23. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome.
Kuroda S; Houkin K; Ishikawa T; Nakayama N; Iwasaki Y
Neurosurgery; 2010 Jun; 66(6):1093-101; discussion 1101. PubMed ID: 20495424
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease.
Kim HG; Lee SK; Lee JD
J Neurosurg Pediatr; 2017 Jan; 19(1):1-7. PubMed ID: 27715484
[TBL] [Abstract][Full Text] [Related]
25. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
27. Regional cerebral hemodynamics in childhood moyamoya disease.
Kuroda S; Houkin K; Kamiyama H; Abe H; Mitsumori K
Childs Nerv Syst; 1995 Oct; 11(10):584-90. PubMed ID: 8556725
[TBL] [Abstract][Full Text] [Related]
28. Direct and combined revascularization in pediatric moyamoya disease.
Golby AJ; Marks MP; Thompson RC; Steinberg GK
Neurosurgery; 1999 Jul; 45(1):50-8; discussion 58-60. PubMed ID: 10414566
[TBL] [Abstract][Full Text] [Related]
29. Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease.
Ross IB; Shevell MI; Montes JL; Rosenblatt B; Watters GV; Farmer JP; O'Gorman AM
Pediatr Neurol; 1994 May; 10(3):199-204. PubMed ID: 8060421
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of moyamoya disease in children: which is more effective procedure, EDAS or EMS?
Fujita K; Tamaki N; Matsumoto S
Childs Nerv Syst; 1986; 2(3):134-8. PubMed ID: 3779669
[TBL] [Abstract][Full Text] [Related]
31. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
32. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
33. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease.
Bang JS; Kwon OK; Kim JE; Kang HS; Park H; Cho SY; Oh CW
Neurosurgery; 2012 Mar; 70(3):625-32; discussion 632-3. PubMed ID: 21866061
[TBL] [Abstract][Full Text] [Related]
34. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
35. Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome.
Im SH; Oh CW; Kwon OK; Cho BK; Chung YS; Han DH
J Neurosurg; 2004 May; 100(5):877-82. PubMed ID: 15137607
[TBL] [Abstract][Full Text] [Related]
36. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment for paediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS).
Matsushima T; Fujiwara S; Nagata S; Fujii K; Fukui M; Kitamura K; Hasuo K
Acta Neurochir (Wien); 1989; 98(3-4):135-40. PubMed ID: 2741743
[TBL] [Abstract][Full Text] [Related]
38. Preservation of the Arachnoid Membrane During Encephaloduroarteriosynangiosis Reduces Postoperative Complications without Undermining the Surgical Outcome in Pediatric Moyamoya Disease.
Byun YH; Phi JH; Lee JY; Ha EJ; Kim KH; Yang J; Kim HS; Ryu SK; Choi JW; Cho BK; Kim SK
World Neurosurg; 2019 Oct; 130():e406-e416. PubMed ID: 31233923
[TBL] [Abstract][Full Text] [Related]
39. Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study.
Yamada I; Matsushima Y; Suzuki S
Neuroradiology; 1992; 34(4):318-22. PubMed ID: 1528443
[TBL] [Abstract][Full Text] [Related]
40. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
